Overview
The U.S. Court of Appeals for the First Circuit has affirmed the dismissal of a putative class action lawsuit against Bayamón Medical Center (BMC), a Puerto Rico-based hospital, stemming from a 2019 ransomware attack. The case, Santos-Pagán v. Bayamón Medical Center, turned on the question of Article III standing — specifically whether the plaintiff could plausibly allege that her claimed injuries were traceable to BMC's breach rather than to some other source.
The court concluded she could not. Although ransomware attacks routinely involve the exposure or exfiltration of patient data, the plaintiff's allegations did not establish a sufficient causal link between the BMC incident and the harms she described. The ruling follows a pattern of federal courts applying a demanding traceability standard to data breach plaintiffs before allowing class litigation to proceed.
The decision does not signal that BMC escaped all legal or regulatory scrutiny — it addresses only the plaintiff's ability to bring a class action in federal court, not the underlying compliance obligations that apply to the hospital as a HIPAA-covered entity.
Key developments
Traceability, not injury type, was the dispositive question. The First Circuit did not rule that the plaintiff suffered no harm; it ruled that she failed to plausibly allege her harm came from BMC's ransomware incident specifically. Courts continue to treat traceability as a distinct element of standing, separate from whether a cognizable injury exists.
The 2019 ransomware attack predates heightened OCR scrutiny of ransomware. HHS OCR issued updated ransomware guidance in 2024, reinforcing that a ransomware event constitutes a presumptive breach under the HIPAA Breach Notification Rule unless a covered entity can demonstrate a low probability that PHI was compromised. The BMC litigation illustrates how legal exposure can persist for years after an incident.
Class action dismissal does not eliminate regulatory risk. A favorable court ruling on Article III standing does not resolve whether OCR reviewed the incident, whether breach notification obligations were met, or whether civil monetary penalties remain available to regulators. Covered entities should not interpret a plaintiff's failed lawsuit as a clean bill of health.
Federal circuit courts are not uniform on standing in breach cases. Different circuits have reached different conclusions about when alleged risk of future identity theft or misuse of data is sufficient injury for standing. The First Circuit's ruling is binding only within its jurisdiction and may diverge from outcomes in the Third, Seventh, or Ninth Circuits.
Industry impact
Data breach class actions against healthcare providers have multiplied alongside the rise in ransomware incidents targeting the sector. HHS OCR reported that large breaches affecting 500 or more individuals reached record levels in recent years, with ransomware identified as a leading cause. Despite the volume of litigation, plaintiffs continue to face significant procedural hurdles: courts have increasingly required concrete, traceable injury rather than speculative future harm or the mere fact of data exposure.
The IBM Cost of a Data Breach Report has consistently ranked healthcare as the sector with the highest average breach cost, exceeding $10 million per incident in recent editions — a figure that reflects regulatory penalties, notification costs, and litigation expenses even when class actions do not ultimately succeed. For smaller hospitals and independent practices, litigation costs alone, regardless of outcome, represent a substantial financial exposure.
The Santos-Pagán decision adds to a growing body of case law that may discourage certain plaintiff-side firms from filing in the First Circuit without stronger causal evidence. It does not, however, reduce the underlying compliance obligations or the likelihood that OCR or state regulators will pursue enforcement independently of private litigation.
What this means for independent practices
- Document incident response thoroughly. When a ransomware event occurs, preserve forensic evidence and investigation records that can demonstrate what data was and was not accessed. This documentation matters both in regulatory investigations and in any subsequent litigation over traceability.
- Complete the HIPAA breach risk assessment in writing. The Breach Notification Rule requires a four-factor risk assessment to determine whether an incident rises to a reportable breach. A written, contemporaneous assessment is the primary defense in both OCR investigations and civil proceedings.
- Do not assume a dismissed lawsuit ends the matter. OCR enforcement timelines are independent of civil litigation. A case that is dismissed on standing grounds may still be within OCR's investigation window, and patients may file complaints separately.
- Review breach notification procedures annually. Practices should confirm that their notification timelines, content requirements, and media-notice thresholds are current with the 2024 OCR ransomware guidance, which treats encryption by an unauthorized actor as a presumptive breach.
- Carry appropriate cyber liability coverage. Even when class actions fail on procedural grounds, the legal defense costs are real. Coverage terms should be reviewed to confirm they extend to regulatory defense and notification expenses, not only settlements.
The Santos-Pagán ruling offers no operational relief for covered entities. The compliance obligations that applied to BMC in 2019 — risk analysis, access controls, incident response planning, breach notification — remain the baseline for every HIPAA-regulated provider regardless of how civil courts rule on standing. Practices that treat a plaintiff's failed lawsuit as validation of their security approach are misreading the signal.
What would have prevented this
Network segmentation: Isolating clinical systems, administrative records, and backup environments from one another limits a ransomware actor's ability to move laterally and encrypt or exfiltrate data across the entire environment. Segmentation reduces the scope of any breach and can make the four-factor risk assessment more defensible.
Immutable, offsite backup systems: Maintaining encrypted backups that cannot be altered or deleted by ransomware actors — and testing restoration procedures regularly — limits both the operational damage of an attack and the period during which PHI may be inaccessible or exposed.
Privileged access monitoring: Ransomware actors frequently escalate privileges before deploying encryption. Continuous monitoring of privileged account activity, with automated alerting on anomalous behavior, can surface an intrusion before data exfiltration occurs.
Audit logging with anomaly detection: Comprehensive logs of who accessed which records, when, and from where create the evidentiary record needed to determine whether PHI was actually viewed or copied — a finding that is central to both the HIPAA risk assessment and to any subsequent litigation over traceability of harm.
Endpoint detection and response (EDR) with rapid containment capabilities: Deploying endpoint-level detection that can isolate a compromised device automatically reduces dwell time and limits the window during which ransomware can propagate, directly narrowing the scope of PHI potentially affected.